News Releases

Jan 14, 2021

Cepheid Receives Health Canada License for SARS-CoV-2, Flu A, Flu B and RSV Combination Test

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season
Sep 29, 2020

Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season
Jul 16, 2020

New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs
Jun 9, 2020

Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV

Four Viral Infections Have Similar Patient Presentations, Making Accurate Detection and Differentiation Critical During Next Flu Season
Mar 21, 2020

Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19

Show per page